相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。WNT receptors profile expression in mature blood cells and immature leukemic cells: RYK emerges as a hallmark receptor of acute leukemia
Monserrat Alvarez-Zavala et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Activating ERBB4 mutations in non-small cell lung cancer
K. J. Kurppa et al.
ONCOGENE (2016)
Prognostic value of ERBB4 expression in patients with triple negative breast cancer
Ji-Yeon Kim et al.
BMC CANCER (2016)
Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors
Yi Du et al.
NATURE MEDICINE (2016)
Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Chia-Wei Li et al.
NATURE COMMUNICATIONS (2016)
Nuclearly translocated insulin-like growth factor 1 receptor phosphorylates histone H3 at tyrosine 41 and induces SNAI2 expression via Brg1 chromatin remodeling protein
Dudi Warsito et al.
ONCOTARGET (2016)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells
Kaleigh Canfield et al.
CELL CYCLE (2015)
Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases
Mei-Kuang Chen et al.
FEBS JOURNAL (2015)
PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response
Hsin-Wei Liao et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Validating ROS1 Rearrangements As a Therapeutic Target in Non-Small-Cell Lung Cancer
Benjamin Solomon
JOURNAL OF CLINICAL ONCOLOGY (2015)
Crizotinib Therapy for Advanced Lung Adenocarcinoma and a ROS1 Rearrangement: Results From the EUROS1 Cohort
Julien Mazieres et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Minireview: Were the IGF Signaling Inhibitors All Bad?
Heather Beckwith et al.
MOLECULAR ENDOCRINOLOGY (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK
Phillip B. Murray et al.
SCIENCE SIGNALING (2015)
Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK
Phillip B. Murray et al.
SCIENCE SIGNALING (2015)
ALK alteration is a frequent event in aggressive breast cancers
Abdul K. Siraj et al.
BREAST CANCER RESEARCH (2015)
The clinical and functional significance of c-Met in breast cancer: a review
Colan M. Ho-Yen et al.
BREAST CANCER RESEARCH (2015)
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
Carlos L. Arteaga et al.
CANCER CELL (2014)
Definition of PKC-α, CDK6, and MET as Therapeutic Targets in Triple-Negative Breast Cancer
Yi-Hsin Hsu et al.
CANCER RESEARCH (2014)
Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: A new era begins
J. Remon et al.
CANCER TREATMENT REVIEWS (2014)
MET is a potential target for use in combination therapy with EGFR inhibition in triple-negative/basal-like breast cancer
Yu Jin Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Successes, toxicities and challenges in solid tumours
Joel W. Neal et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer
Umadevi Thirumurthi et al.
SCIENCE SIGNALING (2014)
Receptor Tyrosine Kinases: Legacy of the First Two Decades
Joseph Schlessinger
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)
The landscape of kinase fusions in cancer
Nicolas Stransky et al.
NATURE COMMUNICATIONS (2014)
Oncogenic ERBB3 Mutations in Human Cancers
Bijay S. Jaiswal et al.
CANCER CELL (2013)
Combination of Antibody That Inhibits Ligand-Independent HER3 Dimerization and a p110α Inhibitor Potently Blocks PI3K Signaling and Growth of HER2+ Breast Cancers
Joan T. Garrett et al.
CANCER RESEARCH (2013)
Molecular Pathways: ROS1 Fusion Proteins in Cancer
Kurtis D. Davies et al.
CLINICAL CANCER RESEARCH (2013)
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered
Hui K. Gan et al.
FEBS JOURNAL (2013)
ErbB3 downregulation enhances luminal breast tumor response to antiestrogens
Meghan M. Morrison et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
HER3 Overexpression and Survival in Solid Tumors: A Meta-analysis
Alberto Ocana et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Cetuximab-mediated Tumor Regression Depends on Innate and Adaptive Immune Responses
Xuanming Yang et al.
MOLECULAR THERAPY (2013)
Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3
Toni M. Brand et al.
PLOS ONE (2013)
Inhibition of Type I Insulin-Like Growth Factor Receptor Signaling Attenuates the Development of Breast Cancer Brain Metastasis
Sandra M. Saldana et al.
PLOS ONE (2013)
ROS1 Expression in Invasive Ductal Carcinoma of the Breast Related to Proliferation Activity
Minseob Eom et al.
YONSEI MEDICAL JOURNAL (2013)
Receptor Tyrosine Kinases in the Nucleus
Graham Carpenter et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
Ron Bose et al.
CANCER DISCOVERY (2013)
A Mechanism for the Upregulation of EGF Receptor Levels in Glioblastomas
Jingwen Zhang et al.
CELL REPORTS (2013)
Presence of anaplastic lymphoma kinase in inflammatory breast cancer
Fredika M. Robertson et al.
SPRINGERPLUS (2013)
Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology
Bengt Hallberg et al.
NATURE REVIEWS CANCER (2013)
Targeting the ERBB family in cancer: couples therapy
Niall Tebbutt et al.
NATURE REVIEWS CANCER (2013)
ErbB4 localization to cardiac myocyte nuclei, and its role in myocyte DNA damage response
Basak Icli et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer
Roxana Schillaci et al.
BMC CANCER (2012)
Role of epidermal growth factor receptor in breast cancer
Hiroko Masuda et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer
G. Minuti et al.
BRITISH JOURNAL OF CANCER (2012)
Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locations
Woody Han et al.
CANCER LETTERS (2012)
Epidermal Growth Factor Receptor Variant III Contributes to Cancer Stem Cell Phenotypes in Invasive Breast Carcinoma
Catherine A. Del Vecchio et al.
CANCER RESEARCH (2012)
ErbB380 kDa, a nuclear variant of the ErbB3 receptor, binds to the Cyclin D1 promoter to activate cell proliferation but is negatively controlled by p14ARF
Laetitia Andrique et al.
CELLULAR SIGNALLING (2012)
Nuclear IGF1R is a transcriptional co-activator of LEF1/TCF
Dudi Warsito et al.
EMBO REPORTS (2012)
Gefitinib resistance in HCC mahlavu cells: Upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation
Adam S. Bodzin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor family
Ying-Nai Wang et al.
CELL AND BIOSCIENCE (2012)
Spatial regulation of receptor tyrosine kinases in development and cancer
Jessica B. Casaletto et al.
NATURE REVIEWS CANCER (2012)
The Wnt receptor Ryk controls specification of GABAergic neurons versus oligodendrocytes during telencephalon development
Jingyang Zhong et al.
DEVELOPMENT (2011)
Nuclear Translocation of Epidermal Growth Factor Receptor by Akt-dependent Phosphorylation Enhances Breast Cancer-resistant Protein Expression in Gefitinib-resistant Cells
Wei-Chien Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Anaplastic lymphoma kinase in human cancer
Antonella Barreca et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2011)
Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
Siyuan Zhang et al.
NATURE MEDICINE (2011)
Feedback regulation of EGFR signalling: decision making by early and delayed loops
Roi Avraham et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Elevated BCRP/ABCG2 Expression Confers Acquired Resistance to Gefitinib in Wild-Type EGFR-Expressing Cells
Yun-Ju Chen et al.
PLOS ONE (2011)
A Perspective on Cancer Cell Metastasis
Christine L. Chaffer et al.
SCIENCE (2011)
Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy
Yvonne Hui-Fang Teng et al.
BREAST CANCER RESEARCH (2011)
Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice
Laura N. Burga et al.
BREAST CANCER RESEARCH (2011)
HER-3 Overexpression Is Prognostic of Reduced Breast Cancer Survival A Study of 4046 Patients
Connie G. Chiu et al.
ANNALS OF SURGERY (2010)
Elevation of Receptor Tyrosine Kinase EphA2 Mediates Resistance to Trastuzumab Therapy
Guanglei Zhuang et al.
CANCER RESEARCH (2010)
Type 1 Insulin-like Growth Factor Receptor Translocates to the Nucleus of Human Tumor Cells
Tamara Aleksic et al.
CANCER RESEARCH (2010)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphorylation at residue Thr654
Klaus Dittmann et al.
FEBS LETTERS (2010)
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
K. David Voduc et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis
Ita Hadzisejdic et al.
MODERN PATHOLOGY (2010)
Progesterone Receptor Induces ErbB-2 Nuclear Translocation To Promote Breast Cancer Growth via a Novel Transcriptional Effect: ErbB-2 Function as a Coactivator of Stat3
Wendy Beguelin et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Diverse somatic mutation patterns and pathway alterations in human cancers
Zhengyan Kan et al.
NATURE (2010)
Understanding resistance to EGFR inhibitors-impact on future treatment strategies
Deric L. Wheeler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
MET signalling: principles and functions in development, organ regeneration and cancer
Livio Trusolino et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors
Young Lim Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation
Fumin Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus
Longfei Huo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone
Edgardo Rivera et al.
BREAST CANCER RESEARCH (2010)
Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells
Emanuela Matteucci et al.
CARCINOGENESIS (2009)
Nuclear Translocation of the Epidermal Growth Factor Receptor Family Membrane Tyrosine Kinase Receptors
Shao-Chun Wang et al.
CLINICAL CANCER RESEARCH (2009)
ErbB receptors and signaling pathways in cancer
Nancy E. Hynes et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Cdc37 Regulates Ryk Signaling by Stabilizing the Cleaved Ryk Intracellular Domain
Jungmook Lyu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Epidermal Growth Factor Receptor Ligands at a Glance
Marlon R. Schneider et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Exon Array Profiling Detects EML4-ALK Fusion in Breast, Colorectal, and Non-Small Cell Lung Cancers
Eva Lin et al.
MOLECULAR CANCER RESEARCH (2009)
Nuclear Expression of Epidermal Growth Factor Receptor is a Novel Prognostic Value in Patients With Ovarian Cancer
Weiya Xia et al.
MOLECULAR CARCINOGENESIS (2009)
Linear combinations of docking affinities explain quantitative differences in RTK signaling
Andrew Gordus et al.
MOLECULAR SYSTEMS BIOLOGY (2009)
Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4
Todd D. Prickett et al.
NATURE GENETICS (2009)
Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer
F. R. Hirsch et al.
ONCOGENE (2009)
Crosstalk in Met receptor oncogenesis
Andrea Z. Lai et al.
TRENDS IN CELL BIOLOGY (2009)
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
Jose Baselga et al.
NATURE REVIEWS CANCER (2009)
Correlates and determinants of nuclear epidermal growth factor receptor content in an oropharyngeal cancer tissue microarray
Amanda Psyrri et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
The HER4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis
Anjali Naresh et al.
CANCER RESEARCH (2008)
A central role for HER3 in HER2-amplified breast cancer:: implications for targeted therapy
Si Tuen Lee-Hoeflich et al.
CANCER RESEARCH (2008)
Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells
David L. Shattuck et al.
CANCER RESEARCH (2008)
Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate
Gail D. Lewis Phillips et al.
CANCER RESEARCH (2008)
Cleavage of the Wnt Receptor Ryk Regulates Neuronal Differentiation during Cortical Neurogenesis
Jungmook Lyu et al.
DEVELOPMENTAL CELL (2008)
The status and role of ErbB receptors in human cancer
I. Ueberall et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2008)
EGFR family: Structure physiology signalling and therapeutic targets
Antony W. Burgess
GROWTH FACTORS (2008)
Epigenetic multiple ligands: Mixed Histone/Protein methyltransferase, acetyltransferase, and class III deacetylase (Sirtuin) inhibitors
Antonello Mai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression
Liang-Yi Hung et al.
NUCLEIC ACIDS RESEARCH (2008)
C-met must translocate to the nucleus to initiate calcium signals
Dawidson A. Gomes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients
Andrea Sassen et al.
BREAST CANCER RESEARCH (2008)
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer
Katrien Berns et al.
CANCER CELL (2007)
STAT-mediated EGFR signaling in cancer
Kelly M. Quesnelle et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB Ligands and remain dependent on the ErbB receptor network
Christoph A. Ritter et al.
CLINICAL CANCER RESEARCH (2007)
Signaling on the endocytic pathway
Mark von Zastrow et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Tissue transglutaminase-mediated chemoresistance in cancer cells
Amit Verma et al.
DRUG RESISTANCE UPDATES (2007)
Drug therapy: Trastuzumab - Mechanism of action and use in clinical practice
Clifford A. Hudis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Bone microenvironment and androgen status modulate subcellular localization of ErbB3 in prostate cancer cells
Chien-Jui Cheng et al.
MOLECULAR CANCER RESEARCH (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer
Maurizio Scaltriti et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain
Mia Thompson et al.
BRAIN RESEARCH (2007)
Prognostic markers in triple-negative breast cancer
Emad A. Rakha et al.
CANCER (2007)
Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esonhaaeal sauamous cell carcinoma
Mina Hoshino et al.
PATHOBIOLOGY (2007)
ERBB3 kinase domain mutations are rare in lung, breast and colon carcinomas
Eun Goo Jeong et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Tyrosine phosphorylation controls PCNA function through protein stability
Shao-Chun Wang et al.
NATURE CELL BIOLOGY (2006)
The epidermal growth factor receptor pathway: A model for targeted therapy
Maurizio Scaltriti et al.
CLINICAL CANCER RESEARCH (2006)
ErbB-4s80 intracellular domain abrogates ETO2-dependent transcriptional repression
Bryan Linggi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Met, the hepatocyte growth factor receptor, localizes to the nucleus in cells at low density
Sharon Pozner-Moulis et al.
CANCER RESEARCH (2006)
EGFR amplification and lack of activating mutations in metaplastic breast carcinomas
J. S. Reis et al.
JOURNAL OF PATHOLOGY (2006)
EGF-ERBB signalling: towards the systems level
Ami Citri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells
Anjali Naresh et al.
CANCER RESEARCH (2006)
Expression and nuclear localization of ErbB3 in prostate cancer
IH Koumakpayi et al.
CLINICAL CANCER RESEARCH (2006)
EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus
M Hanawa et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Wnt signaling: complexity at the surface
KM Cadigan et al.
JOURNAL OF CELL SCIENCE (2006)
Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells
GE Konecny et al.
CANCER RESEARCH (2006)
Insulin-like growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells
R Nahta et al.
CANCER RESEARCH (2005)
Secretase-dependent tyrosine phosphorylation of Mdm2 by the ErbB-4 intracellular domain fragment
RR Arasada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase
K Dittmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis
A Psyrri et al.
CLINICAL CANCER RESEARCH (2005)
EGFR gene amplification in breast cancer:: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations
R Bhargava et al.
MODERN PATHOLOGY (2005)
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway
HW Lo et al.
CANCER CELL (2005)
Wnt signalling in stem cells and cancer
T Reya et al.
NATURE (2005)
Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients
WY Lee et al.
CLINICAL CANCER RESEARCH (2005)
Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells
TT Junttila et al.
CANCER RESEARCH (2005)
c-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu
E Lengyel et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2
SC Wang et al.
CANCER CELL (2004)
Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers:: an immunohistochemical and fluorescent in situ hybridization study
A Ooi et al.
MODERN PATHOLOGY (2004)
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
Y Nagata et al.
CANCER CELL (2004)
The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone
CC Williams et al.
JOURNAL OF CELL BIOLOGY (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase
SK Rabindran et al.
CANCER RESEARCH (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prognostic value of ERBB family mRNA expression in breast carcinomas
I Bièche et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Expression of the HERI-4 family of receptor tyrosine kinases in breast cancer
CJ Witton et al.
JOURNAL OF PATHOLOGY (2003)
The deaf and the dumb: the biology of ErbB-2 and ErbB-3
A Citri et al.
EXPERIMENTAL CELL RESEARCH (2003)
Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth
DB Agus et al.
CANCER CELL (2002)
Rat MUC4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for Herceptin resistance
SA Price-Schiavi et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
c-erbB-3:: a nuclear protein in mammary epithelial cells
M Offterdinger et al.
JOURNAL OF CELL BIOLOGY (2002)
EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma
D Liu et al.
CANCER CELL (2002)
Phosphorylation on tyrosine-15 of p34Cdc2 by ErbB2 inhibits p34Cdc2 activation and is involved in resistance to taxol-induced apoptosis
M Tan et al.
MOLECULAR CELL (2002)
Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer
S Tsutsui et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase
CY Ni et al.
SCIENCE (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Nuclear localization of EGF receptor and its potential new role as a transcription factor
SY Lin et al.
NATURE CELL BIOLOGY (2001)
Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma
R Gilbertson et al.
GENES CHROMOSOMES & CANCER (2001)
The type III epidermal growth factor receptor mutation - Biological significance and potential target for anti-cancer therapy
MW Pedersen et al.
ANNALS OF ONCOLOGY (2001)
The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification
N Prenzel et al.
ENDOCRINE-RELATED CANCER (2001)
Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases
H Waterman et al.
FEBS LETTERS (2001)
Untangling the ErbB signalling network
Y Yarden et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
D Harari et al.
ONCOGENE (2000)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
